Announced
Completed
Synopsis
Biotage, a provider of technologies and solutions in the areas of genetic analysis and medicinal chemistry, completed the acquisition of ATDBio, a designer and synthesiser of complex oligonucleotides, for £45m. “ATDBio is very proud to become part of the Biotage family, which shares our passion for innovation, customer focus and sustainability. We will now be able to scale up even further thanks to the global presence and world-leading separation science expertise of Biotage. We will continue to innovate, helping our customers to bring the next generation of nucleic acid molecular diagnostics, vaccines and therapeutics to the market,” Tom Brown Jr, ATDBio Director.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.